Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 180 shares, an increase of 386.5% from the July 15th total of 37 shares. Based on an average daily trading volume, of 2,823 shares, the short-interest ratio is currently 0.1 days.
Analysts Set New Price Targets
Several analysts recently issued reports on CZMWY shares. UBS Group lowered shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research report on Tuesday. Zacks Research raised Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold”.
Read Our Latest Analysis on CZMWY
Carl Zeiss Meditec Stock Performance
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Further Reading
- Five stocks we like better than Carl Zeiss Meditec
- A Westinghouse IPO Could Reset the Nuclear Stock Conversation
- Fastly’s Q2 Rally Shows Investors Are Buying the Edge AI Turnaround
- Paramount’s 30-Film Promise Puts AMC Back in the Box Office Conversation
- DraftKings’ Predictions Push Could Be the Bet That Matters Most
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
